Personalis

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Personalis and other ETFs, options, and stocks.

About PSNL

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives.

CEO

Christopher M. Hall

CEOChristopher M. Hall

Employees

229

Employees229

Headquarters

Fremont, California

HeadquartersFremont, California

Founded

2011

Founded2011

Employees

229

Employees229

PSNL Key Statistics

Market cap

431.91M

Market cap431.91M

Price-Earnings ratio

-3.79

Price-Earnings ratio-3.79

Dividend yield

—

Dividend yield—

Average volume

957.85K

Average volume957.85K

High today

$4.93

High today$4.93

Low today

$4.63

Low today$4.63

Open price

$4.87

Open price$4.87

Volume

419.24K

Volume419.24K

52 Week high

$7.20

52 Week high$7.20

52 Week low

$1.14

52 Week low$1.14

PSNL News

TipRanks 18h

Guggenheim starts Personalis with a Buy, cites ‘best-in-class infrastructure’

As previously reported, Guggenheim initiated coverage of Personalis (PSNL) with a Buy rating and $6 price target Personalis has built a best-in-class infrastruc...

TipRanks 21h

Personalis initiated with a Buy at Guggenheim

Guggenheim initiated coverage of Personalis (PSNL) with a Buy rating and $6 price target Published first on TheFly – the ultimate source for real-time, market-...

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

People also own

Based on the portfolios of people who own PSNL. This list is generated using Robinhood data, and it’s not a recommendation.